← Open Payments lookup

NASER KALANI YAZD: Open Payments

NPI 1326064726 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,697 in 131 payments from 21 companies in 2025. Trend: 2023 $3,111 · 2024 $2,549 · 2025 $3,697

Food & beverage: $3,630Education: $66
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$455
ABBVIE INC.17$447
Teva Pharmaceuticals USA, Inc.9$385
Bayer Healthcare Pharmaceuticals Inc.12$317
Alkermes, Inc.10$284
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$261
Neurocrine BioSciences, Inc.7$254
Aimmune Therapeutics, Inc.9$240
Sumitomo Pharma America, Inc.12$212
Otsuka America Pharmaceutical, Inc.5$192

Products named: Kerendia, INGREZZA, ZENPEP, XIFAXAN, GEMTESA, AIRSUPRA, REXULTI, BREZTRI.

Industry payments across CO — which companies pay providers there.